© Mercedes-Benz Grand Prix Ltd.
At the onset of the COVID-19 pandemic, Mercedes co-developed the CPAP breathing aids in cooperation with University College London.
The Continuous Positive Airway Pressure (CPAP) devices have been developed by Mercedes-AMG High Performance Powertrains (Mercedes’ F1 engine factory) and the University College London as part of Formula 1’s Project Pitlane. The project focused on F1 teams developing ventilators to help those suffering from COVID-19.
Ten thousand breathing aids have been promptly delivered to British hospitals in 2020, and later shipped all around the world. The design has since been made available for copying free of charge and is now locally produced in India, Pakistan, South Africa and Mexico.
If you like SilverArrows.Net, consider supporting us by buying us a coffee!
The President of University College London Dr Michael Spence now says the device is being used in at least 15 countries around the world.
“The development of the UCL-Ventura is a remarkable story of scientific breakthrough innovation and collaboration between UK universities, hospitals and industry,” Spence said.
“The speed with which the breathing aid was produced and approved for use on the NHS was startling and we are proud that it is now helping to save the lives of seriously-ill COVID-19 patients in over 130 hospitals in the UK and at least 15 countries around the world.”
